Amarin Corp Plc (AMRN)

[me33]

Mineral oil subject is dead. The most reasonable explanation is the Anchor trial washout period simply wasn't long enough which btw plays in favor of V.
If someone can't understand the difference between 465mg and 3,800mg of EPA, that 375mg of DHL in Lovaza raises LDL, that patients in ASCEND didn't have high trigs and other risk factors as patients in RI. Then they deserve to miss out on this opportunity. In fact, if they can't comprehend basic stuff like this they should not be investing at all.
The bottom line, RI will be successful. ASCEND failure will make V case only stronger. V will get CVD label and access to multi billion market which it will dominate.